BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 12529823)

  • 1. [Risk estimation in Barrett's esophagus: biomolecular marker and histopathologic classification].
    Walch A; Schmitt-Gräff A; Stein H; Werner M
    Zentralbl Chir; 2002 Dec; 127(12):1073-7. PubMed ID: 12529823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrett's oesophagus: from metaplasia to dysplasia and cancer.
    Fléjou JF
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i6-12. PubMed ID: 15711008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
    Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL
    Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms in Barrett's metaplasia and its progression.
    Izzo JG; Luthra R; Wu TT; Correa AM; Luthra M; Anandasabapathy S; Chao KS; Hung MC; Aggarwal B; Hittelman WN; Ajani JA
    Semin Oncol; 2007 Apr; 34(2 Suppl 1):S2-6. PubMed ID: 17449347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of early neoplasia in Barrett's mucosa based on changes in surface structure. Comparative stereo-microscopic and histological investigations in 600 endoscopically resected specimens.
    Dostler I; Ell C; Neuhaus H; Stolte M
    Z Gastroenterol; 2010 May; 48(5):542-5. PubMed ID: 20449786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there an advantage to be gained from adding digital image cytometry of brush cytology to a standard biopsy protocol in patients with Barrett's esophagus?
    Borovicka J; Schönegg R; Hell M; Kradolfer D; Bauerfeind P; Dorta G; Netzer P; Binek J; Meyenberger C; Fischer JE; Spieler P
    Endoscopy; 2009 May; 41(5):409-14. PubMed ID: 19418394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological assessment of oesophageal columnar mucosa.
    Flejou JF
    Best Pract Res Clin Gastroenterol; 2008; 22(4):671-86. PubMed ID: 18656824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and recognition of early esophageal neoplasia.
    Herszényi L; Pregun I; Tulassay Z
    Dig Dis; 2009; 27(1):24-30. PubMed ID: 19439957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic alterations in malignant transformation of Barrett's esophagus.
    Riegman PH; Vissers KJ; Alers JC; Geelen E; Hop WC; Tilanus HW; van Dekken H
    Cancer Res; 2001 Apr; 61(7):3164-70. PubMed ID: 11306503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of methylene blue-directed biopsies and four-quadrant biopsies in the detection of high-grade intraepithelial neoplasia and early cancer in Barrett's oesophagus.
    Gossner L; Pech O; May A; Vieth M; Stolte M; Ell C
    Dig Liver Dis; 2006 Oct; 38(10):724-9. PubMed ID: 16911879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histology of metaplasia and dysplasia in Barrett's esophagus.
    Yerian L
    Surg Oncol Clin N Am; 2009 Jul; 18(3):411-22. PubMed ID: 19500733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risk in Barrett's oesophagus.
    Dias Pereira A; Suspiro A; Chaves P
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curative treatment for high-grade intraepithelial neoplasia in Barrett's esophagus.
    Behrens A; May A; Gossner L; Günter E; Pech O; Vieth M; Stolte M; Seitz G; Ell C
    Endoscopy; 2005 Oct; 37(10):999-1005. PubMed ID: 16189774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-segment Barrett's esophagus associated with high-grade dysplasia.
    Morita K; Fujimori T; Ono Y; Masuyama H; Nakamura T; Terano A
    J Gastroenterol; 2002; 37(12):1083-5. PubMed ID: 12522544
    [No Abstract]   [Full Text] [Related]  

  • 19. Confocal laser scanning fluorescence microscopy for in vivo determination of microvessel density in Barrett's esophagus.
    Becker V; Vieth M; Bajbouj M; Schmid RM; Meining A
    Endoscopy; 2008 Nov; 40(11):888-91. PubMed ID: 19009480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Barrett's esophagus. Metaplasia-dysplasia-cancer: inexorable change?].
    Tamayo de la Cuesta JL
    Rev Gastroenterol Mex; 2003 Nov; 68 Suppl 3():40-4. PubMed ID: 15146792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.